Skip to main content
    A

    Azenta Inc (AZTA)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $47.22
    +1.57 (+3.44%)

    Market Cap: $1.91B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Azenta Inc (AZTA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Azenta are BioLife Solutions (BLFS), Kestra Medical Technologies, Ltd. Common Stock (KMTS) and LeMaitre Vascular (LMAT). Azenta trades at 96.4x earnings, against a median of 21.2x for the 9 of these companies with a P/E. By market cap, Azenta ranks 6th of the 13 companies on this page; Merit Medical Systems (MMSI) is the largest at $5.19B.

    Peer Comparison

    AZTA's revenue growth of 5.1% is below the peer median of 7.3%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Azenta (AZTA)$1.91B96.4x3.5x-26.9%N/A5.1%0.00%
    BioLife Solutions Inc (BLFS)$1.89B241.3x18.4x54.3%N/A21.5%0.00%
    Kestra Medical Technologies, Ltd. Common Stock (KMTS)$1.71BN/A15.3x-140.4%-48.8%59.9%0.00%
    LeMaitre Vascular Inc (LMAT)$1.79B28.0x6.5x23.5%9.5%11.3%1.30%
    STAAR Surgical Company (STAA)$1.32B35.2x4.0x0.2%N/A-12.0%0.00%
    Pulse Biosciences Inc (PLSE)$3.71BN/AN/A0.0%N/A359.3%0.00%
    Dentsply Sirona Inc (XRAY)$1.83B6.6x0.5x-3.4%0.1%-7.5%7.15%
    Envista Holdings Corp (NVST)$3.93B15.5x1.3x22.0%14.7%3.2%0.00%
    Stevanato Group SpA (STVN)$4.32B19.9x3.0x11.3%7.1%7.6%0.40%
    ICU Medical Inc (ICUI)$4.48B22.7x2.1x2.8%3.2%4.4%0.00%
    Embecta Corp (EMBC)$366.02M3.1x0.3x8.6%18.4%-8.1%0.64%
    Merit Medical Systems Inc (MMSI)$5.19B21.2x3.2x9.9%7.0%8.4%0.00%
    AngioDynamics Inc (ANGO)$499.19MN/A1.5x-10.1%N/A6.9%0.00%
    Peer median$1.86B21.2x3.0x5.7%7.0%7.3%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Azenta, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Medical Instruments & Supplies.

    CompanyAboutPeers
    BioLife Solutions Inc (BLFS)
    BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the gene and cell therapy industry in the United States...
    Kestra Medical Technologies, Ltd. Common Stock (KMTS)
    Kestra Medical Technologies, Ltd. is a wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington.
    KMTS competitors
    LeMaitre Vascular Inc (LMAT)
    LeMaitre Vascular, Inc. designs, markets, sells, services and supports medical devices and implants for the treatment of peripheral vascular diseases worldwide.
    LMAT competitors
    STAAR Surgical Company (STAA)
    STAAR Surgical Company designs, develops, manufactures, markets and sells implantable eye lenses and supplemental delivery systems for placing the lenses...
    STAA competitors
    Pulse Biosciences Inc (PLSE)
    Pulse Biosciences, Inc. is a bioelectrical medicine startup. The company is headquartered in Hayward, California.
    PLSE competitors
    Dentsply Sirona Inc (XRAY)
    Dentsply Sirona is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries.
    XRAY competitors
    Envista Holdings Corp (NVST)
    Envista Holdings Corporation, develops, manufactures and markets dental products in the United States and internationally.
    NVST competitors
    Stevanato Group SpA (STVN)
    Stevanato Group SpA (STVN) is a leading global provider of advanced drug delivery systems...
    STVN competitors
    ICU Medical Inc (ICUI)
    ICU Medical, Inc. develops, manufactures and sells medical devices used in infusion therapy and critical care applications worldwide.
    ICUI competitors
    Embecta Corp (EMBC)
    Embecta Corp (EMBC) is a leading medical technology company specializing in innovative insulin delivery systems aimed at enhancing diabetes management.
    EMBC competitors
    Merit Medical Systems Inc (MMSI)
    Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology...
    MMSI competitors
    AngioDynamics Inc (ANGO)
    AngioDynamics, Inc. designs, manufactures and sells various medical, surgical and diagnostic devices for the treatment of peripheral vascular disease...
    ANGO competitors

    Frequently Asked Questions About AZTA

    Who are Azenta's main competitors?

    The companies most similar to Azenta include BioLife Solutions (BLFS), Kestra Medical Technologies, Ltd. Common Stock (KMTS), LeMaitre Vascular (LMAT), STAAR Surgical Company (STAA) and Pulse Biosciences (PLSE), listed from the closest match.

    Who is Azenta's biggest competitor?

    Merit Medical Systems (MMSI) is the largest of the similar companies at $5.19B; BioLife Solutions (BLFS) is the closest match by business profile, size, sector and industry.

    How does AZTA stock compare with its competitors?

    AZTA's P/E is 96.4x against a peer median of 21.2x; its P/S is 3.5x against a peer median of 3.0x; its net margin is -26.9% against a peer median of 5.7%.

    Which of Azenta's competitors pays a higher dividend?

    Azenta pays no dividend. Dentsply Sirona (XRAY), LeMaitre Vascular (LMAT), Embecta (EMBC) and Stevanato Group SpA (STVN) have higher forward dividend yields; Dentsply Sirona (XRAY) has the highest at 7.15%.

    Is Azenta bigger than its competitors?

    No. Azenta is 6th by market cap among the 13 companies on this page; the largest is Merit Medical Systems (MMSI) at $5.19B.